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ABSTRACT
Objectives To determine the additional prognostic value
of mitral regurgitation (MR) over B-type natriuretic
peptide (BNP), left ventricular ejection fraction (LVEF)
and clinical characteristics in patients with acute
coronary syndromes (ACS).
Design Long-term follow-up in a prospective ACS cohort
with Doppler-assessed MR, echocardiographically-
determined LVEF and plasma BNP levels by ELISA.
Setting Single-centre university hospital.
Patients 725 patients with ACS.
Main outcome measures Death and readmission for
congestive heart failure.
Results During a median follow-up of 98 months, 235
patients (32%) died. Signiﬁcant MR (grade >1 of 4) was
found in 90 patients (12%). In a multivariate model
including MR grade >1, LVEF <0.40 and BNP >373 pg/
ml (75th percentile), MR was signiﬁcantly associated
with long-term mortality (HR 2.28, 95% CI 1.67 to 3.12;
p<0.0001). When also adjusting for conventional risk
factors, MR remained signiﬁcantly associated with
mortality (HR 1.53, 95% CI 1.06 to 2.19; p¼0.02), as
well as with congestive heart failure (HR 2.08, 95% CI
1.29 to 3.35; p¼0.003).
Conclusions MR is common in patients with ACS,
provides independent risk information and should be
taken into account in the evaluation of the long-term
prognosis.
Left ventricular (LV) systolic function is a major
prognostic determinant in coronary artery disease,
and a close relation between LV ejection fraction
(LVEF) and mortality has been demonstrated.
1e4
In the clinical setting, echocardiography is
a commonly used method for determination of LV
function. In addition to evaluation of LVEF,
Doppler echocardiography also permits assessment
of the degree of mitral regurgitation (MR).
Although long recognised as a prognostic factor in
heart failure and myocardial infarction (MI),
5e8
limited data are available on the prognostic value
of MR in the full spectrum of acute coronary
syndromes (ACS).
9
Circulating levels of B-type natriuretic peptide
(BNP), a cardiac-derived biomarker, are associated
with LV function, and BNP has emerged as an
important diagnostic tool in congestive heart
failure (CHF). BNP and the N-terminal fragment
(NT-proBNP) of its prohormone (proBNP) have
also been shown to be independently predictive of
mortality in patients with ACS,
3 4 as well as in
patients with stable coronary disease.
21 0Notably,
in patients with asymptomatic or symptomatic
MR and decreased LVEF, BNP has been shown to
increase in proportion to the severity of MR.
11
Moreover, in a study of consecutive patients with
CHF, a signiﬁcant association between higher levels
of BNP and moderate to severe MR was observed,
12
suggesting that some of the prognostic merit of
BNP may be ascribed to its reﬂection of the
magnitude of MR. It is unknown, however,
whether indices of LV systolic function, MR
severity and BNP levels provide independent and
incremental prognostic information to each other.
Thus, in the present study we ﬁrst sought to
evaluate whether MR adds prognostic information
above that obtained from BNP and LVEF in ACS.
Second, we assessed whether the presence of
signiﬁcant MR, increased BNP levels and decreased
LVEF, alone or in combination, provided prognostic
information above and beyond conventional clin-
ical risk factors for the long-term outcome in ACS.
METHODS
Patient population
Consecutive patients admitted to the coronary care
unit of the Sahlgrenska University Hospital,
Gothenburg, Sweden with suspected ACS and
evaluated for participation in a study of prognosis
and its prediction in ACS,
13 were included between
December 1996 and March 2001. To enable long-
term follow-up, only patients aged <80 years and
living within the catchment area of the hospital
were eligible. Patients transferred from other
hospitals for tertiary care were not included. The
main exclusion criteria were severe non-coronary
artery disease associated with a life expectancy of
<1 year or unwillingness to participate. A patient
could only be included once.
The suspicion of ACS had to be supported by
ECG changes on admission, biochemical markers
above the upper reference level or previously
recognised coronary artery disease.
13
Based on ECG and biochemical markers of
myocardial ischaemia and necrosis, the patients
were diagnosed as ST-segment elevation MI
(STEMI), non-STEMI or unstable angina pectoris
(UAP). STEMI was further subdivided according to
anterior (including lateral), inferior (including
posterior) and unspeciﬁed locations.
Information on earlier hospital admissions, risk
factors and medication was obtained from hospital
medical records and personal interviews. Date of
death and survival conﬁrmation at 1 January 2008
was obtained from the Swedish National Popula-
tion Registry, and information on rehospitalisation
for CHF (International Statistical Classiﬁcation of
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Acute coronary syndromesDisease, Ninth Revision (ICD-9) code 428 or Tenth Revision
(ICD-10) code 150) up to January 2008 from the Swedish
Hospital Discharge Register.
Blood samples
Peripheral blood samples for plasma BNP determination were
obtained in the acute phase within 24 h of hospital admission by
direct venipuncture of an antecubital vein after the patient had
been in the supine position for >30 min. The samples were drawn
into prechilled ethylenediamine tetraacetic acid (EDTA) tubes,
immediately placed on ice and centrifuged at 3000 rpm within 1 h.
EDTA plasma samples were aspirated and stored at  808C until
analysis (median (25th, 75th percentiles) 58 (46, 81) months). BNP
levels in plasma were measured by a ﬂuorescence immunoassay
from Biosite Diagnostics (San Diego, California, USA). Interassay
and intra-assay coefﬁcients of variation for the BNP measurements
were 9e12% in the low, medium and high ranges. There was
a weak inverse relation between BNP levels and days of storage
(r¼ 0.076, p¼0.042). Glomerular ﬁltration rate was estimated by
the Cockroft and Gault formula. Renal dysfunction was deﬁned as
calculated creatinine clearance <60 ml/min.
Echocardiography
Echocardiographic investigations including continuous wave
Doppler recordings were performed by an experienced operator
within 5 days after hospital admissions. Biplane LVEF was
calculated by the disc summation method and tracings were
checked in motion mode for accuracy, as described previously.
3 14
LVEF <0.40 was regarded as reduced systolic LV function.
15
The grade of MR was determined from colour and continuous
wave Doppler recordings based on the regurgitation ﬂow
intensity and classiﬁed into ﬁve grades.
16 Grade 0 denoted no
regurgitation or regurgitation limited to a small part of early
systole; grade 1 indicated mild regurgitation weakly visible
during the whole of systole; grade 2 was moderate regurgitation
clearly visible throughout systole; grade 3 was deﬁned by large
regurgitation intensely visible during the whole of systole; and
grade 4 signiﬁed severe regurgitation as found, for example, in
chordal rupture with a large intensity and altered shape of the
spectral Doppler proﬁle (sharp and often a visible V wave effect
rather than a rounded proﬁle). In grades 3e4 the regurgitation
usually reached the roof of the left atrium and, particularly in
grade 4, swirled around. In grade 3e4 there was also usually
a volume load on the left ventricle and reversed systolic
pulmonary venous ﬂow.
Statistical analyses
Categorical variables are reported as percentages and continuous
variables as medians. We used dichotomised BNP (>75th
percentile), LVEF (<0.40) and MR (grade >1) for the analyses. A
score deﬁned as the number of these three factors present was
also calculated and analysed.
The association between dichotomised BNP, LVEF and MR
and baseline demographic characteristics and clinical risk factors
was assessed by the Fisher exact test for proportions and the
ManneWhitney U test for continuous/ordered variables.
The KaplaneMeier method was used for estimation of
cumulative mortality curves. In the ﬁgures these are only shown
for the ﬁrst 10 years, although the complete follow-up infor-
mation until 1 January 2008 was used to calculate HRs and p
values. Univariate mortality comparisons were performed using
the log rank test, and multivariate mortality analyses as well as
HR calculations (with corresponding 95% CIs) were performed
using the Cox proportional hazards model. In the multivariable
analyses we adjusted for potential confounders deemed to be
clinically relevant (age, gender, smoking, diabetes, hypertension,
hypercholesterolaemia, prior MI, prior angina, prior CHF, prior
percutaneous coronary intervention/coronary artery bypass
grafting, estimated creatinine clearance and diagnosis). All
p values are two-tailed and considered signiﬁcant if <0.05.
RESULTS
The study population comprised 725 patients (515 men and 210
women) of mean6SD age 65610 years with STEMI (n¼343),
Table 1 Baseline characteristics of patients above or below the respective cut-off levels for MR grade, LVEF and plasma BNP
All patients
(n[725)
MR >1/£1
(n[90/635) p Value
LVEF <0.40/‡0.40
(n[110/615) p Value
BNP >373/£373
(n[180/545) p Value
Mean age (years) 65 70/64 <0.0001 70/64 <0.0001 70/63 <0.0001
Female (%) 29 39/28 0.05 24/30 0.17 37/27 0.01
History (%)
MI 20 36/18 0.0002 36/17 <0.0001 29/17 0.001
Angina pectoris 40 59/38 0.0002 43/40 0.60 47/38 0.04
CHF 8 27/5 <0.0001 22/5 <0.0001 17/5 <0.0001
PCI/CABG 12 21/11 0.02 16/12 0.21 15/12 0.24
Risk factors (%)
Current smoker 34 27/35 0.18 38/33 0.32 30/35 0.27
Diabetes mellitus 18 26/17 0.04 18/18 0.89 21/17 0.26
Hypertension 40 51/39 0.03 42/40 0.75 51/37 0.0008
Hypercholesterolaemia 28 31/28 0.53 32/27 0.36 24/29 0.22
GFR <60 ml/min 38 62/35 <0.0001 53/36 0.001 59/31 <0.0001
Diagnosis (%)
STEMI 47 43/48 0.43 49/47 0.76 46/48 0.73
Anterior 48 26/50 0.004 74/43 <0.0001 57/45 0.06
Inferior 50 64/49 0.09 19/56 <0.0001 39/54 0.02
Unspeciﬁed 2 10/<1 0.004 7/1 0.01 5/1 0.06
Non-STEMI 35 43/34 0.10 39/35 0.39 46/32 0.0006
Unstable angina pectoris 17 13/18 0.37 12/18 0.10 8/21 <0.0001
10-year mortality (%) 36.3 70.2/31.5 <0.0001 67.5/30.7 <0.0001 56.3/29.4 <0.0001
BNP, brain natriuretic peptide; CABG, coronary artery bypass grafting; CHF, congestive heart failure; GFR, glomerular ﬁltration rate; LVEF, left ventricular ejection fraction; MI, myocardial
infarction; MR, mitral regurgitation, PCI, percutaneous coronary intervention; STEMI, ST segment elevation myocardial infarction.
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Acute coronary syndromesnon-STEMI (n¼256) or UAP (n¼126). BNP measurements were
performed in the acute phase and an echocardiographic exami-
nation with estimation of LVEF and the degree of MR was
carried out within 5 days of admission. Among all the patients
the MR grade was inversely related to LVEF (r¼ 0.32,
p<0.0001) and directly related to BNP (r¼0.41, p<0.0001).
Ninety patients (12%) had an MR grade >1, 110 patients
(15%) had an LVEF <0.40 and 180 patients (25%) had BNP
levels above the 75th percentile (373 pg/ml). The characteristics
of all the patients are shown in table 1 with patients divided
into the following subgroups: with or without signiﬁcant MR,
with or without depressed LV function and with BNP above or
below the 75th percentile. Patients in the groups with signiﬁ-
cant MR, low LVEF and high BNP were older and more often
had a history of MI and CHF. Hypertension and previous angina
were more common in the groups with MR grade >1 and higher
BNP, while there was no difference between the LVEF
subgroups. The proportion of women was higher among
patients with high BNP and tended to be high in patients with
MR. Previous revascularisation and diabetes were more common
in patients with MR than in those without. There were no
differences in index diagnosis between the MR groups or
between the LVEF groups, but non-STEMI was more common
in patients with high BNP levels than in those with lower levels,
while the opposite was true for UAP. In the subgroups of
STEMI, anterior location was associated with lower LVEF
(p<0.0001) and a higher BNP level (p¼0.001) but lower MR
grade (p¼0.027) than inferior location. As shown in table 1, in
patients with larger MR the proportion of anterior MI was
lower and the proportion of inferior MI tended to be higher
than in those with minor MR. On the other hand, with LVEF
<0.40 anterior MI was more prevalent and inferior MI was less
prevalent than with LVEF $0.40.
Two hundred and thirty-ﬁve patients (32.4%) died during
a median (25th and 75th percentiles) follow-up time of 98 (75,
117) months. MR, reduced LVEF and high BNP levels were all
signiﬁcantly associated with long-term mortality, as shown in
ﬁgure 1 and table 2.
In a model that included MR, LVEF and BNP, all three vari-
ables remained signiﬁcant predictors of mortality (table 2,
multivariate model 1). After adjustment for clinical confounders,
each variable also independently predicted death (multivariate
model 2). Furthermore, when MR, LVEF and BNP were forced
into the same model together with clinical variables (multivar-
iate model 3), all three factors remained signiﬁcantly associated
with long-term mortality (HR for MR 1.53 (95% CI 1.06 to
2.19), p¼0.02; HR for LVEF 1.94 (95% CI 1.38 to 2.73),
p¼0.0001; and HR for BNP 1.45 (95% CI 1.06 to 1.99), p¼0.02,
table 2). The C-statistic (81 months of follow-up) for MR
alone was 0.594 compared with 0.669 for MR+LVEF and 0.711
for MR+LVEF+BNP.
Figure 2 shows the mortality curves for patients having none,
one or 2e3 of signiﬁcant MR, low LVEF and high BNP, and
illustrates how the mortality increases with a higher score
(ﬁgure 2A). The combination of the non-invasive variables
without BNP is also shown (ﬁgure 2B).
MR, LVEF and BNP all showed a signiﬁcant univariate asso-
ciation with readmission to hospital for CHF (table 2). After
adjustment for potential confounders and taken into the same
model, MR (HR 2.08, 95% CI 1.29 to 3.35, p¼0.003) and LVEF
(HR 3.41, 95% CI 2.14 to 5.42, p<0.0001) still remained signif-
icant predictors of readmission to hospital for CHF, while a trend
in the same direction was seen for BNP (HR 1.51, 95% CI 0.96 to
2.33, p¼0.07).
DISCUSSION
In this prospective outcome study of patients with ACS,
the presence of a signiﬁcant MR had prognostic implications
and provided independent information over that obtained
from the combination of reduced LVEF, high BNP and
clinical risk factors. Thus, MR grade >1 independently
predicted long-term mortality as well as readmission to hospital
for CHF.
Figure 1 KaplaneMeier curves showing the cumulative incidence of
death in relation to (A) mitral regurgitation (MR) grade >1o r#1; (B) left
ventricular ejection fraction (LVEF) <0.40 or $0.40; and (C) B-type
natriuretic peptide (BNP) >373 pmol/l (75th percentile) or #373 pmol/l
in patients with acute coronary syndromes.
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Acute coronary syndromesPrognostic value of mitral regurgitation
ACS may result in varying degrees of ischaemic injury and
subsequent LV dysfunction. Numerous studies have shown that
the degree of LV systolic dysfunction is a majordif not the most
importantddeterminant of long-term outcome in ACS.
17
Development of MR during ACS may be due to ischaemic injury
of the papillary muscle apparatus and/or dilation of the left
ventricle and has been linked to death and development of heart
failure in patients with acute MI independently of LVEF and
clinical confounders.
15 18 19 In addition, MR has been linked
with adverse outcome in patients with STEMI undergoing
a percutaneous coronary intervention.
20 Our results conﬁrm and
extend the ﬁndings of these previous studies
91 51 92 12 2by
showing that MR adds prognostic information to that of LVEF
and BNP across the spectrum of ACS.
BNP and mitral regurgitation
The B-type natriuretic peptides BNP and NT-proBNP are asso-
ciated with the degree of LV dysfunction following ACS, but
still provide prognostic information independently of LVEF
3 42 3
and the Thrombolysis In MI (TIMI) risk score.
24 In the present
study we used BNP, which has been found to be as accurate as
NT-proBNP for identifying CHF.
25 The volume overload and
stretch of the atrial and ventricular myocardium associated with
MR are potent stimuli for natriuretic peptide release, suggesting
that in some patients the prognostic information obtained from
BNP is partly derived from its reﬂection of MR grade. However,
although MR is more common in patients with LV dysfunction,
the association between MR grade and LVEF is not linear as
unloading of the ventricle tends to increase LVEF.
26 As conﬁrmed
in our patients, despite less LV dysfunction, inferior MI has been
found to be associated with a higher incidence of MR than
anterior MI, possibly due to more severe geometric changes in
the mitral apparatus.
27 Accordingly, the interrelationship
between reduced LV function, MR grade and circulating BNP
levels is a complex one. Indeed, in the current study we show for
the ﬁrst time that the prognostic information obtained from MR
grade and BNP in ACS is complementary and signiﬁcant when
LVEF is also considered. In the full multivariable model which
included conventional clinical risk factors, MR grade was still
providing prognostic information beyond that obtained from
BNP and LVEF.
Prognostic value of the score system
Despite a number of studies on the prognostic value of MR as
well as natriuretic peptides after an MI, we found no informa-
tion on the long-term prognostic value of the combined infor-
mation from MR, LVEF and BNP in ACS or MI. To determine
whether a combination of the three study variables (MR, LVEF
and BNP) provided superior prognostic information to that
Table 2 HRs (95% CIs) for the association of long-term mortality to baseline MR, LVEF and BNP
Univariate p Value
Multivariate model 1
including MR, LVEF
and BNP (or MR/LVEF*
and BNP) p Value
Multivariate model 2
including MR or LVEF or
BNP or MR/LVEF* +
confoundersy p Value
Multivariate model 3
including MR, LVEF
and BNP (or MR/LVEF*
and BNP) + confoundersy p Value
All-cause mortality
MR >1.0 3.25 (2.41 to 4.37) <0.0001 2.28 (1.67 to 3.12) <0.0001 1.82 (1.29 to 2.59) 0.0007 1.53 (1.06 to 2.19) 0.02
LVEF <0.40 3.48 (2.63 to 4.61) <0.0001 2.38 (1.76 to 3.23) <0.0001 2.34 (1.70 to 3.22) <0.0001 1.94 (1.38 to 2.73) 0.0001
BNP >373 pmol/l 2.86 (2.20 to 3.72) <0.0001 1.96 (1.47 to 2.61) <0.0001 1.79 (1.33 to 2.40) 0.0001 1.45 (1.06 to 1.99) 0.02
MR/LVEF score* 2.81 (2.33 to 3.38) <0.0001 2.33 (1.90 to 2.85) <0.0001 1.88 (1.51 to 2.34) <0.0001 1.73 (1.38 to 2.17) <0.0001
Readmission to hospital for CHF
MR >1.0 3.84 (2.52 to 5.86) <0.0001 2.58 (1.66 to 4.01) <0.0001 2.49 (1.56 to 3.96) 0.0001 2.08 (1.29 to 3.35) 0.003
LVEF <0.40 5.14 (3.49 to 7.57) <0.0001 3.54 (2.33 to 5.38) <0.0001 4.14 (2.65 to 6.47) <0.0001 3.41 (2.14 to 5.42) <0.0001
BNP >373 pmol/l 3.30 (2.27 to 4.80) <0.0001 2.01 (1.34 to 3.03) 0.0008 2.12 (1.38 to 3.24) 0.0005 1.51 (0.96 to 2.38) 0.07
MR/LVEF score* 3.66 (2.82 to 4.74) <0.0001 3.03 (2.29 to 4.02) <0.0001 2.91 (2.15 to 3.94) <0.0001 2.66 (1.94 to 3.65) <0.0001
*Per step in 0e1e2 score, where MR grade >1 and LVEF <0.40 were assigned one score point each.
yAdjusted for age, gender, smoking, diabetes, hypertension, hypercholesterolaemia and history of diabetes, MI, angina, CHF, PCI/CABG, GFR <60 ml/min and current diagnosis of ACS type.
ACS, acute coronary syndromes; BNP, brain natriuretic peptide; CABG, coronary artery bypass grafting; CHF, congestive heart failure; GFR, glomerular ﬁltration rate; LVEF, left ventricular
ejection fraction; MI, myocardial infarction; MR, mitral regurgitation, PCI, percutaneous coronary intervention.
A
B
Figure 2 Cumulative incidence of death in relation to (A) risk score 0, 1
and 2e3 where mitral regurgitation (MR) grade >1, left ventricular
ejection fraction (LVEF) <0.40 and BNP >373 pmol/l (75th percentile)
yielded one score point each; and (B) risk score 0, 1 and 2 where MR
grade >1 and LVEF <0.40 contributed one score point each.
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Acute coronary syndromesobtained from entering individual variables, we generated
a simple score system. Interestingly, a full score in the two-
factor model was associated with higher risk than a score of 2e3
points in the three-factor model, suggesting that, even if inclu-
sion of BNP in the model may be helpful for identifying low-risk
patients, it seems less important for identifying high-risk
patients when LVEF and MR grade are available. Our two-factor
score system of MR and LVEF showed a signiﬁcant association
with readmission to hospital for CHF in a multivariate model
including both MR/LVEF and BNP. Echocardiography allows
determination of several prognostic indicators after acute MI.
28
The combined information of MR and LVEF seems to contain
strong supplementary prognostic information. An important
advantage is that they are easily obtained in the same echocar-
diographic investigation, which is now often routinely
performed in patients with ACS.
17
Strengths and limitations
Strengths of the current study include a large contemporary
patient sample and long duration of follow-up. However, there
are also potential important limitations.
We stored plasma at  808C to allow uniform BNP measure-
ments on one occasion with minimal methodological variation.
Although we cannot exclude some degradation of BNP over
time, only a very weak relation to days of storage was noted.
The study design used does not permit distinction between
pre-existing MR and MR developed following the ischaemic
event. Clearly, MR existing before the ACS event might also
have affected subsequent prognosis. As this hospital admission
was the ﬁrst contact with emergency care for most patients,
information on pre-existing MR grade was not generally avail-
able in our study cohort. The same limitation has been discussed
by Bursi et al
18 in a cohort study with acute MI, and is a limi-
tation common to this and all similar studies.
Other limitations include the potential effect of a change in
the acute treatment strategy of ACS during the study periodd
that is, a higher proportion of patients underwent early percu-
taneous coronary intervention in the late part of the recruitment
period than in the early part. These treatment changes may have
affected the incidence of MR and the predictive values of the
study variables to some extent. However, acute reperfusion in
patients with MR in relation to MI does not seem to reduce the
mortality rate to the level noted with less MR.
8 Furthermore,
there is no real consensus on how to grade the magnitude of
MR. The assessment of MR in our study was based on a semi-
quantitative grading of continuous and colour Doppler images
by an experienced operator, but other methods have also been
described.
61 8
CONCLUSION
In summary, information concerning MR grade provides
important prognostic information across the spectrum of ACS.
Evaluation of LV function, MR grade and BNP levels each
provide complementary prognostic information to conventional
clinical risk factors. A scoring system based on these three
variables or MR and LVEF alone represents a risk-stratifying
instrument of potential clinical utility. However, its validation
in a new study cohort is required before it can be generally
recommended.
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Images in cardiology
‘Classic’ supravalvular aortic stenosis
A 16-year-old boy with a history of gradually progressive
dyspnoea on exertion was referred as a case of severe aortic
stenosis. On examination he was found to have a 4/6 ejection
systolic murmur at the base of the heart radiating to both
carotids and decreased pulses on the left upper limb. EKG
revealed features of left ventricular hypertrophy. Echocardiog-
raphy showed normal left ventricular function with hyper-
trophy, tri-leaﬂet aortic valve with good opening of leaﬂets and
supravalvular aortic narrowing. On diagnostic cardiac catheter-
isation there was no gradient across the aortic valve, but
a gradient of 150 mm Hg in the ascending aorta (Panel A).
Angiography revealed tubular narrowing of the ascending aorta,
dilated aortic sinuses and coronary arteries, typical of supra-
valvular aortic stenosis (Panel B). In addition, there was
involvement of the aortic arch vessels in the form of mild ostial
stenosis of the right brachiocephalic trunk with fusiform dila-
tation of the artery and tight ostial stenosis of the left common
carotid artery. Digital subtraction angiography of the aortic arch
and branch vessels conﬁrmed these ﬁndings. Angiogram of the
pulmonary arteries and the renal arteries revealed no abnor-
mality. He lacked features suggestive of WilliamseBeuren
syndrome, with a normal facies and normal serum calcium
levels.
This case illustrates the classic haemodynamic and angio-
graphic features of this well-known yet uncommon entity.
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Panel A Pullback pressure tracing
from left ventricle to ascending aorta to
descending aorta, showing no gradient
across the aortic valve, but a gradient of
150 mm Hg across the supravalvular
ascending aorta.
Panel B Aortic root angiogram in the left and right anterior oblique
projections showing the typical tubular narrowing of the ascending
aorta, dilated aortic sinuses and dilated coronary arteries. Ostial stenosis
of the left common carotid artery is also visible.
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